The kidney, a cardiovascular risk marker, and a new target for therapy.
about
Prevalence of chronic kidney disease in population-based studies: systematic reviewHypertension and hyperglycemia synergize to cause incipient renal tubular alterations resulting in increased NGAL urinary excretion in ratsMeasurement of renal function in patients with chronic kidney diseaseChronic kidney disease and end-stage renal disease-a review produced to contribute to the report 'the status of health in the European union: towards a healthier Europe'.Reliability of pre-transplant live donor renal biopsies in predicting the graft outcomeMechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes.Prevalence of CKD in northeastern Italy: results of the INCIPE study and comparison with NHANES.The incremental treatment of ESRD: a low-protein diet combined with weekly hemodialysis may be beneficial for selected patientsChronic kidney disease requiring healthcare services: a new approach to evaluate epidemiology of renal disease.Association of dietary sodium and potassium intakes with albuminuria in normal-weight, overweight, and obese participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.Prevention of chronic kidney disease: the next step forward!Initial implementation of a web-based consultation process for patients with chronic kidney disease.Health-Risk Factors and the Prevalence of Chronic Kidney Disease: Cross-Sectional Findings from a National Cohort of 87,143 Thai Open University Students.Long-term nephrotoxicity in adult survivors of childhood cancer.Quality of chronic kidney disease management in primary care: a retrospective studyPlasma polyunsaturated fatty acids and the decline of renal function.Early detection of chronic kidney disease: results of the PolNef study.Recent findings on the effects of marine-derived n-3 polyunsaturated fatty acids on urinary albumin excretion and renal function.Of heart and kidney: a complicated love story.Eicosapentaenoic and Docosahexaenoic Acids Attenuate Progression of Albuminuria in Patients With Type 2 Diabetes Mellitus and Coronary Artery DiseaseDoppler ultrasound in kidney diseases: a key parameter in clinical long-term follow-up.Prevalence of chronic kidney disease in a representative sample of the Polish population: results of the NATPOL 2011 survey.Chronic kidney disease prevalence in the general population: heterogeneity and concerns.Perceived Barriers and Support Strategies for Reducing Sodium Intake in Patients with Chronic Kidney Disease: a Qualitative Study.The prevalence of chronic kidney disease in the general population in Romania: a study on 60,000 persons.Prevalence and cardiovascular risk profile of chronic kidney disease in Italy: results of the 2008-12 National Health Examination Survey.Expression of TNFRSF6B in kidneys is a novel predictor for progression of chronic kidney disease.General practitioners' perspectives on management of early-stage chronic kidney disease: a focus group study.Illness perceptions and treatment perceptions of patients with chronic kidney disease: Different phases, different perceptions?Interactive effect of retinopathy and macroalbuminuria on all-cause mortality, cardiovascular and renal end points in Chinese patients with Type 2 diabetes mellitus
P2860
Q21257215-243A7FCD-A08F-4B81-B7C0-5932C633A030Q21558791-9D189EDA-4D4B-43F3-B800-1BB0023657A1Q26853698-63E8CB60-BD03-4E45-B318-A07E6352FE74Q33816875-A681981B-DE3F-4611-B8C0-46E26BF56C4DQ33872078-4CBB591A-603E-4DE9-8511-B0BF479A4DD2Q34331403-9BBF55B9-4DBF-4612-B7CB-B520A74C0684Q34405409-D3CBC1AB-E97E-4FF1-A5B6-3E20117CA2A0Q34515472-CC66D6A2-B948-4B6C-A2B3-FD4FD98C477AQ34645981-1210D8DE-50E5-4C81-8982-57A5D8B6D34CQ35212969-4B06C6DE-D4A4-48DF-B814-43C036873A1EQ36498437-52472E08-9A1A-4C1C-885D-E6FA8A96A6E7Q36695675-890DAD06-40D7-4D98-A07D-556247366C45Q36718105-4AB1BBBA-70E8-48A6-B478-6DBD13548A7BQ36910939-1E5192A6-D5B4-41AA-A25A-E9EE42350628Q37013569-E2609DE7-F1E8-41BC-A7E7-8FE2E7B8A36CQ37104534-2EF5655A-D219-473B-96A6-16BA3CC1301AQ37449570-9EDC5358-31DE-41E4-BC6D-7066D87A2A5AQ38034098-B7677E1C-6448-4CE8-A946-B4C84671AD73Q38046611-A3D24A26-EDDB-4D10-BA56-1289C1F8896FQ38373937-C214455E-FA05-4D41-8BFF-7B7F9D444715Q39037990-2236EC9E-E665-486D-8D74-A6C681F445B7Q40330075-5B0F3B25-E9A5-4EBD-9C19-BFEC3286BF33Q40891501-CA07ADD8-1AA0-437F-B160-6395CE6D977DQ42687292-D979E281-F053-4D31-9CBA-D17AA43CC38DQ45264077-F0E47608-1D05-4206-AEEB-B3365B03D18AQ50992595-D34DC4A5-4748-4AF8-A5BD-A485D0FBBDD9Q53118344-8550A0BD-042B-4DA7-891D-063F75530431Q55402013-858E0366-AB29-4974-BD13-AB741C99B3B4Q58078696-2C584CB4-037B-4CCE-8ED2-CF5AAD92FEE6Q58209731-2647AC1D-5DDE-4338-A62B-AA49D9DD56C9
P2860
The kidney, a cardiovascular risk marker, and a new target for therapy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The kidney, a cardiovascular risk marker, and a new target for therapy.
@ast
The kidney, a cardiovascular risk marker, and a new target for therapy.
@en
type
label
The kidney, a cardiovascular risk marker, and a new target for therapy.
@ast
The kidney, a cardiovascular risk marker, and a new target for therapy.
@en
prefLabel
The kidney, a cardiovascular risk marker, and a new target for therapy.
@ast
The kidney, a cardiovascular risk marker, and a new target for therapy.
@en
P2093
P1476
The kidney, a cardiovascular risk marker, and a new target for therapy.
@en
P2093
Dick de Zeeuw
Hans L Hillege
Paul E de Jong
P356
10.1111/J.1523-1755.2005.09805.X
P577
2005-09-01T00:00:00Z